Cargando…
Kallikreins as Biomarkers for Prostate Cancer
The introduction of testing for prostate-specific antigen (PSA), a member of the fifteen-gene family of kallikrein-related peptidases and also known as kallikrein-related peptidase 3 (KLK3), in blood has revolutionized both the detection and management of prostate cancer. Given the similarities betw...
Autor principal: | Hong, Sung Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997884/ https://www.ncbi.nlm.nih.gov/pubmed/24809052 http://dx.doi.org/10.1155/2014/526341 |
Ejemplares similares
-
Kallikrein gene family as biomarkers for recurrent prostate cancer
por: Busra Boyukozer, Fatma, et al.
Publicado: (2020) -
Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015) -
Association between three genetic variants in kallikrein 3 and prostate cancer risk
por: Ding, Wei-Hong, et al.
Publicado: (2018) -
Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
por: Vilhelmsson Timmermand, O., et al.
Publicado: (2016) -
Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application
por: Fuhrman-Luck, Ruth A., et al.
Publicado: (2014)